Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,724.00
(
0.29%
)
News Focus
News Focus

Replies to post #188033 on Biotech Values

Replies to #188033 on Biotech Values
icon url

DewDiligence

03/02/15 6:59 PM

#188045 RE: DewDiligence #188033

RVNC expects phase-2 data from the head-to-head trial of RT002 vs Botox in glabellar lines by late 2015. (Source: today's 4Q14 CC.)